TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-14 Cr | ₹-20 Cr | ₹-9.69 Cr | ₹-0.45 Cr |
What is the latest Cash Flow from Investing Activities ratio of TRIDENT LIFELINE ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹-20 Cr |
| Mar2023 | ₹-9.69 Cr |
| Mar2022 | ₹-0.45 Cr |
How is Cash Flow from Investing Activities of TRIDENT LIFELINE Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹-20 Cr | Negative | |
| Mar2023 | ₹-9.69 Cr | Negative | |
| Mar2022 | ₹-0.45 Cr | - | |
Compare Cash Flow from Investing Activities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹300.8 Cr | -5.1% | 1.3% | -7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,591.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,512.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,850.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,884.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,339.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -5.1% |
1.3% |
-7.8% |
| SENSEX | 0.9% |
-3.6% |
-7.3% |
You may also like the below Video Courses